Compositions and methods for improved delivery of hydrophobic agents
AssigneeLipocine Inc.
InventorsMahesh V. Patel, Feng-Jing Chen
Life of this patent
Estimating the term…
Abstract
The present invention relates to triglyceride-free pharmaceutical compositions for delivery of hydrophobic therapeutic agents. Compositions of the present invention include a hydrophobic therapeutic agent and a carrier, where the carrier is formed from a combination of a hydrophilic surfactant and a hydrophobic surfactant. Upon dilution with an aqueous solvent, the composition forms a clear, aqueous dispersion of the surfactants containing the therapeutic agent. The invention also provides methods of treatment with hydrophobic therapeutic agents using these compositions.
Claims120
A pharmaceutical formulation for administration of a hydrophobic lipid-regulating agent, comprising a therapeutically effective amount of the lipid-regulating agent and a carrier comprised of
- (a) at least one hydrophilic surfactant selected from the group consisting of hydrophilic non-ionic surfactants, hydrophilic ionic surfactants, and combinations thereof, and
- (b) at least one hydrophobic surfactant having an HLB value less than about 10 and selected from the group consisting of alcohols;
- polyoxyethylene alkylethers;
- fatty acids;
- glycerol fatty acid monoesters;
- glycerol fatty acid diesters;
- acetylated glycerol fatty acid monoesters;
- acetylated glycerol fatty acid diesters, lower alcohol fatty acid esters;
- polyethylene glycol fatty acid esters;
- polyethylene glycol glycerol fatty acid esters;
- polypropylene glycol fatty acid esters;
- polyoxyethylene glycerides;
- lactic acid derivatives of monoglycerides;
- lactic acid derivatives of diglycerides;
- propylene glycol diglycerides;
- sorbitan fatty acid esters;
- polyoxyethylene sorbitan fatty acid esters;
- polyoxyethylene-polyoxypropylene block copolymers;
- transesterified vegetable oils;
- sterols;
- sterol derivatives;
- sugar esters;
- sugar ethers;
- sucroglycerides;
- polyoxyethylene vegetable oils;
- polyoxyethylene hydrogenated vegetable oils, reaction products of polyols and at least one member of the group consisting of fatty acids, glycerides, vegetable oils, hydrogenated vegetable oils, and sterols;
- and mixtures thereof,
- said hydrophilic and hydrophobic surfactants being present in amounts such that upon dilution with an aqueous solution at an aqueous solution to carrier ratio of 100:1 by weight, the carrier forms a clear aqueous dispersion having an absorbance of less than about 0.1 at a wavelength of about 400 nm, and wherein the composition is substantially free of glycerol triesters of C6 to about C25 fatty acids.
A pharmaceutical formulation for administration of a hydrophobic therapeutic agent, comprising a therapeutically effective amount of the therapeutic agent and a carrier comprised of
- (a) at least one hydrophilic surfactant selected from the group consisting of hydrophilic non-ionic surfactants, hydrophilic ionic surfactants, and combinations thereof, and
- (b) at least one hydrophobic surfactant having HLB value less than about 10 and selected from the group consisting of alcohols;
- polyoxyethylene alkylethers;
- fatty acids;
- glycerol fatty acid monoesters;
- glycerol fatty acid diesters;
- acetylated glycerol fatty acid monoesters;
- acetylated glycerol fatty acid diesters, lower alcohol fatty acid esters;
- polyethylene glycol fatty acid esters;
- polyethylene glycol glycerol fatty acid esters;
- polypropylene glycol fatty acid esters, polyoxyethylene glycerides;
- lactic acid derivatives of monoglycerides;
- lactic acid derivatives of diglycerides;
- propylene glycol diglycerides;
- sorbitan fatty acid esters;
- polyoxyethylene sorbitan fatty acid esters, polyoxyethylene-polyoxypropylene block copolymers;
- transesterified vegetable oils;
- sterols;
- sterol derivatives;
- sugar esters;
- sugar ethers;
- sucroglycerides;
- polyoxyethylene vegetable oils;
- polyoxyethylene hydrogenated vegetable oils;
- reaction products of polyols and at least one member of the group consisting of fatty acids, glycerides, vegetable oils, hydrogenated vegetable oils, and sterols;
- and mixtures thereof,
- said hydrophilic and hydrophobic surfactants being present in amounts such from upon dilution with an aqueous solution at an aqueous solution to carrier ratio of 10:1 by weight, the carrier forms a clear aqueous dispersion having an absorbance of less than about 0.3 at a wavelength of about 400 nm, and wherein the composition is substantially free of glycerol triesters of C6 to about C25 fatty acids.
A pharmaceutical formulation for administration of a hydrophobic lipid-regulating agent, comprising a therapeutically effective amount of the lipid-regulating agent and a carrier comprised of
- (a) at least one hydrophilic surfactant selected from the group consisting of hydrophilic non-ionic surfactants, hydrophilic ionic surfactants, and combinations thereof, and
- (b) at least one hydrophobic surfactant having an HLB value less than about 10 and selected from the group consisting of alcohols;
- polyoxyethylene alkylethers;
- fatty acids;
- glycerol fatty acid monoesters;
- glycerol fatty acid diesters;
- acetylated glycerol fatty acid monoesters;
- acetylated glycerol fatty acid diesters, lower alcohol fatty acid esters;
- polyethylene glycol fatty acid esters;
- polyethylene glycol glycerol fatty acid esters;
- polypropylene glycol fatty acid esters;
- polyoxyethylene glycerides;
- lactic acid derivatives of monoglycerides;
- lactic acid derivatives of digylcerides;
- propylene glycol diglycerides;
- sorbitan fatty acid esters;
- polyoxyethylene sorbitan fatty acid esters;
- polyoxyethylene-polyoxypropylene block copolymers;
- transesterified vegetable oils;
- sterols;
- sterol derivatives;
- sugar esters;
- sugar ethers;
- sucroglycerides;
- polyoxyethylene vegetable oils;
- polyoxyethylene hydrogenated vegetable oils;
- reaction products of polyols and at least one member of the group consisting of fatty acids, glycerides, vegetable oils, hydrogenated vegetable oils, and sterols;
- and mixtures thereof,
- said hydrophilic and hydrophobic surfactants being present in amounts such that upon dilution with an aqueous solution at an aqueous solution to carrier ratio of 10:1 by weight, the carrier forms a clear aqueous dispersion having an absorbance of less than about 0.3 at a wavelength of about 400 nm, and wherein the composition is substantially free of glycerol triesters of C6 to about C25 fatty acids.
A pharmaceutical formulation for administration of a hydrophobic sex hormone, comprising a therapeutically effective amount of the sex hormone and a carrier comprised of
- (a) at least one hydrophilic surfactant selected from the group consisting of hydrophilic non-ionic surfactants, hydrophilic ionic surfactants, and combinations thereof, and
- (b) at least one hydrophobic surfactant having an HLB value less than about 10 and selected from the group consisting of alcohols;
- polyoxyethylene alkylethers;
- fatty acids;
- glycerol fatty acid monoesters;
- glycerol fatty acid diesters;
- acetylated glycerol fatty acid monoesters;
- acetylated glycerol fatty acid diesters, lower alcohol fatty acid esters;
- polyethylene glycol fatty acid esters;
- polyethylene glycol glycerol fatty acid esters;
- polypropylene glycol fatty acid esters;
- polyoxyethylene glycerides;
- lactic acid derivatives of monoglycerides;
- lactic acid derivatives of diglycerides;
- propylene glycol diglycerides;
- sorbitan fatty acid esters;
- polyoxyethylene sorbitan fatty acid esters;
- polyoxyethylene-polyoxypropylene block copolymers;
- transesterified vegetable oils;
- sterols, sterol derivatives;
- sugar esters;
- sugar ethers;
- sucroglycerides;
- polyoxyethylene vegetable oils;
- polyoxyethylene hydrogenated vegetable oils;
- reaction products of polyols and at least one member of the group consisting of fatty acids, glycerides, vegetable oils, hydrogenated vegetable oils, and sterols;
- and mixtures thereof,
- said hydrophilic and hydrophobic surfactants being present in amounts such that upon dilution with an aqueous solution at an aqueous solution to carrier ratio of 100:1 by weight, the carrier forms a clear aqueous dispersion having an absorbance of less than about 0.1 at a wavelength of about 400 mn, and wherein the composition is substantially free of glycerol triesters of C6 to about C25 fatty acids.
Dependencies are inferred from the claim text.